newsfilter
← Latest News
ACCESS Newswire·

Pieris Pharmaceuticals To Participate In Upcoming Investor Conferences

BOSTON, MA / ACCESSWIRE / November 11, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and